Tus kws kho mob
QP42-18 Addition of Drugs to the Cystic Fibrosis Transmembrane Conductance Regulator PA with QL Program
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 06, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2391 - 2400 ntawm 4303
Tus kws kho mob
QP48-18 Referral Create, Inquiry and Update Functions Available on Availity
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2018
Tus kws kho mob
QP54-18 Medical Drug Exclusion Lists Expanded to Include Synojoynt
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 28, 2018
Tus kws kho mob
QP43-18 Addition of Drugs to the Oral Immunotherapy PA with QL Program
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 06, 2018
Tus kws kho mob
QP8-18 Effective January 1, 2018 FEP Standard Option Subscriber SNF Benefit
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 05, 2018
Tus kws kho mob
QP1-16 Changes to SecureBlue (MSHO) Prescription Drug Coverage
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 07, 2016
Tus kws kho mob
QP18-17 Reminder Regarding PCA Assessment Requests
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 27, 2017
Tus kws kho mob
QP5-17 Pharmacy Benefit Update - EpiPen, EpiPen Jr., Auvi-Q and Procysbi
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 06, 2017
Tus kws kho mob
QP55-18 New Drug - Epidiolex (cannabidiol) will Require Prior Authorization
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 28, 2018
Tus kws kho mob
QP27-18 Post Service Claim Appeals
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 24, 2018